Overview

• Judge Brian C. Walsh signed off on July 1 for Anne Wojcicki’s TTAM Research Institute to acquire 23andMe after topping Regeneron’s bid
• The purchase covers the Personal Genome Service, research operations and the Lemonaid Health telemedicine unit
• TTAM is bound to honor existing privacy policies for roughly 15 million customer profiles and implement additional security measures
• States including California, Kentucky, Tennessee, Texas and Utah remain formally opposed and are evaluating next legal steps
• All customers will receive advance email notices at least two business days before closing with instructions to delete data or opt out of research